rosiglitazone has been researched along with alitretinoin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bu, X; Du, J; Hu, Y; Li, F; Liang, B; Lu, D; Shang, N; Wen, G; Yang, Y; Yu, Y; Yue, X; Zhou, B; Zhuang, W | 1 |
| Gege, C; Hoffmann, T; Schlüter, T | 1 |
| Alvarez, JG; Evans, RM; Nagy, L; Thomazy, VA; Tontonoz, P | 1 |
| Albrektsen, T; Gustafsson, JA; Johansson, L; Leers, J; Treuter, E | 1 |
| Aviram, M; Bisgaier, CL; Newton, RS; Zhu, L | 1 |
| Clapham, JC; Smith, SA; Teruel, T | 1 |
| Bledsoe, RK; Gampe, RT; Kliewer, SA; Lambert, MH; Milburn, MV; Miller, AB; Montana, VG; Willson, TM; Xu, HE | 1 |
| Blumentrath, J; Neye, H; Verspohl, EJ | 1 |
| Ahn, IS; Do, MS; Hong, SE; Jung, HS; Rayner, DV | 1 |
| Akerblad, P; Améen, C; Asp, L; Edvardsson, U; Lindén, D; Ljungberg, A; Olofsson, SO; Oscarsson, J; Tuneld, A | 1 |
| Allred, CD; Kilgore, MW | 1 |
| Giralt, M; Hondares, E; Iglesias, R; Mora, O; Rodriguez de la Concepción, M; Villarroya, F; Yubero, P | 1 |
| Aeed, H; Bruck, R; Halpern, Z; Pines, M; Weiss, S; Zvibel, I | 1 |
| Dushkin, MI; Khoshchenko, OM; Posokhova, EN; Schvarts, YSh | 1 |
| Andò, S; Bonofiglio, D; Catalano, S; Cione, E; Fuqua, SA; Genchi, G; Panno, ML; Perri, M; Pingitore, A; Qi, H; Vizza, D | 1 |
| Andò, S; Bonofiglio, D; Catalano, S; Cione, E; Genchi, G; Perri, M; Pingitore, A; Qi, H; Rovito, D; Vizza, D | 1 |
| Aoki, A; Hiromori, Y; Ido, A; Kimura, T; Nagase, H; Nakanishi, T | 1 |
| Miao, J; Pan, L; Wang, Q; Wu, M; Zhao, A | 1 |
| Azam, F; Bello, M | 1 |
20 other study(ies) available for rosiglitazone and alitretinoin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Benzoates; Benzylamines; Brain; Cell Line; Chalcones; Flavones; Hep G2 Cells; Humans; Hydrocarbons, Fluorinated; Lipids; Liver X Receptors; Mice; Mice, Transgenic; Microglia; Molecular Docking Simulation; Orphan Nuclear Receptors; Plaque, Amyloid; Presenilin-1; Promoter Regions, Genetic; Signal Transduction; Structure-Activity Relationship; Sulfonamides; Triglycerides | 2013 |
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
Topics: Benzeneacetamides; Drug Inverse Agonism; Fluorescence Resonance Energy Transfer; Humans; Ligands; Nuclear Receptor Subfamily 1, Group F, Member 2; Nuclear Receptor Subfamily 1, Group F, Member 3; Protein Binding; Th17 Cells; Thiazoles; Tretinoin | 2014 |
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.
Topics: Alitretinoin; Animals; Arteriosclerosis; CD36 Antigens; Cell Differentiation; Dimerization; Foam Cells; HL-60 Cells; Humans; Ligands; Lipoproteins, LDL; Macrophages; Membrane Proteins; Mice; Mice, Transgenic; Monocytes; Promoter Regions, Genetic; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Retinoic Acid; Receptors, Scavenger; Retinoid X Receptors; Rosiglitazone; Scavenger Receptors, Class B; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tretinoin | 1998 |
A regulatory role for RIP140 in nuclear receptor activation.
Topics: Adaptor Proteins, Signal Transducing; Alitretinoin; Amino Acid Sequence; Animals; Binding, Competitive; Cell Nucleus; Cloning, Molecular; Dimerization; DNA-Binding Proteins; Fatty Acids; Gene Expression Regulation; Gene Library; Histone Acetyltransferases; Humans; Macromolecular Substances; Molecular Sequence Data; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Nuclear Receptor Coactivator 1; Nuclear Receptor Coactivators; Nuclear Receptor Interacting Protein 1; Oncogene Proteins; Pyrimidines; Rabbits; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Recombinant Fusion Proteins; Repressor Proteins; Retinoid X Receptors; Rosiglitazone; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin; Zinc Fingers | 1998 |
9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells.
Topics: Alitretinoin; Blood Cells; Chemokine CCL2; Dose-Response Relationship, Drug; Humans; Monocytes; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 1999 |
PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
Topics: Adipose Tissue, Brown; Alitretinoin; Animals; Carrier Proteins; Cells, Cultured; Gene Expression Regulation; Ion Channels; Membrane Proteins; Mitochondrial Proteins; Peroxisome Proliferators; Promoter Regions, Genetic; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tretinoin; Uncoupling Protein 1 | 1999 |
Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.
Topics: Alitretinoin; Amino Acid Sequence; Binding Sites; Crystallography; Diabetes Mellitus, Type 2; Dimerization; Drug Design; Histone Acetyltransferases; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Nuclear Proteins; Nuclear Receptor Coactivator 1; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Sequence Homology, Amino Acid; Surface Properties; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin | 2000 |
Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells.
Topics: Alitretinoin; Animals; Binding Sites; Blotting, Northern; Blotting, Western; Cell Division; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Glucose; Glucose Transporter Type 2; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Monosaccharide Transport Proteins; Proinsulin; Protein Precursors; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tretinoin | 2001 |
Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro.
Topics: Adipocytes; Alitretinoin; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation; Glycerol; Isomerism; Leptin; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin | 2004 |
Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver.
Topics: Alitretinoin; Animals; Apolipoproteins B; Carrier Proteins; Cell Line; Cells, Cultured; Dactinomycin; Gene Expression Regulation; Hepatocytes; Liver; Male; Mice; Mice, Inbred C57BL; PPAR alpha; Promoter Regions, Genetic; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Tretinoin | 2005 |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Topics: Alitretinoin; Anilides; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; HT29 Cells; Humans; Ligands; Lung Neoplasms; PPAR gamma; Prostaglandin D2; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection; Tretinoin | 2005 |
Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coacti
Topics: 3T3-L1 Cells; Adipocytes; Alitretinoin; Animals; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Homeostasis; Hypoglycemic Agents; Mice; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Response Elements; Rosiglitazone; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcriptional Activation; Tretinoin | 2006 |
Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor.
Topics: Alitretinoin; Animals; Cell Proliferation; Collagen Type I; Cytokines; Drug Synergism; Hepatic Stellate Cells; Liver Cirrhosis, Experimental; Male; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thioacetamide; Tretinoin | 2009 |
Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation.
Topics: Alitretinoin; Animals; Bezafibrate; Cholesterol; Cholesterol Esters; Foam Cells; Inflammation; Injections, Intraperitoneal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; PPAR alpha; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin; Triglycerides; Tumor Necrosis Factor-alpha; Zymosan | 2007 |
Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Ligands; NF-kappa B; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin; Tumor Suppressor Protein p53 | 2009 |
Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Ligands; Mitochondria; PPAR gamma; Retinoid X Receptors; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Tretinoin; Tumor Suppressor Protein p53; Up-Regulation | 2011 |
Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
Topics: Alitretinoin; Arsenicals; Cell Line, Tumor; DNA; Genes, Reporter; Humans; Ligands; Luciferases, Renilla; Organometallic Compounds; Organophosphorus Compounds; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Terphenyl Compounds; Thiazolidinediones; Transcription, Genetic; Tretinoin | 2016 |
Use of GAL4 factor-based yeast assay to quantify the effects of xenobiotics on RXR homodimer and RXR/PPAR heterodimer in scallop Chlamys farreri.
Topics: Alitretinoin; Animals; Chlorides; Endocrine Disruptors; Ligands; Organotin Compounds; Pectinidae; Peroxisome Proliferators; PPAR alpha; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Saccharomyces cerevisiae; Xenobiotics | 2022 |
Microsecond MD Simulations to Explore the Structural and Energetic Differences between the Human RXRα-PPARγ vs. RXRα-PPARγ-DNA.
Topics: Alitretinoin; Carrier Proteins; DNA; Humans; Ligands; Molecular Dynamics Simulation; PPAR gamma; Rosiglitazone | 2022 |